Národný Onkologický Ústav

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

Giuseppe Roberto D’Agostino, J. Del Campo, Begoña Mellado et al. · International Journal of Gynecological Cancer · 2006 · 83 citations

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Guy Jérusalem, Gabriella Mariani, Eva Ciruelos et al. · Annals of Oncology · 2016 · 72 citations · Full text

Endocrine Oncology, Metastatic Breast Cancer, Breast Oncology +15

Cancer epidemiology in Central and South Eastern European countries

Eduard Vrdoljak, Marek Z. Wojtukiewicz, Tadeusz Pieńkowski et al. · Croatian Medical Journal · 2011 · 60 citations · Full text

Large cell calcifying Sertoli cell tumor: a clinicopathologic study of 1 malignant and 3 benign tumors using histomorphology, immunohistochemistry, ultrastructure, comparative genomic hybridization, and polymerase chain reaction analysis of the PRKAR1A gene

Fredrik Petersson, Stela Bulimbašić, Radek Šíma et al. · Human Pathology · 2009 · 49 citations

Large Cell, Malignant Disease, Medicine +9

Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation Study

W.W. ten Bokkel Huinink, Jozef Šufliarský, Willem M. Smit et al. · Journal of Clinical Oncology · 2009 · 48 citations

Chemoprevention Strategy, Cancer Management, Gynecology +16